Clinical PET-MR Imaging in Breast Cancer and Lung Cancer.
Hybrid imaging systems have dramatically improved thoracic oncology patient care over the past 2 decades. PET-MR imaging systems have the potential to further improve imaging of thoracic neoplasms, resulting in diagnostic and therapeutic advantages compared with current MR imaging and PET-computed tomography systems. Increasing soft tissue contrast and lesion sensitivity, improved image registration, reduced radiation exposure, and improved patient convenience are immediate clinical advantages. Multiparametric quantitative imaging capabilities of PET-MR imaging have the potential to improve understanding of the molecular mechanisms of cancer and treatment effects, potentially guiding improvements in diagnosis and therapy.
Division of Nuclear Medicine, Department of Radiology, New York University Langone Medical Center, 660 First Avenue, New York, NY 10016, USA.
Samuel L
SL
Rice
Division of Nuclear Medicine, Department of Radiology, New York University Langone Medical Center, 660 First Avenue, New York, NY 10016, USA. Electronic address: kent.friedman@nyumc.org.
Kent P
KP
Friedman
D001940:Breast / Q000000981:diagnostic imaging; D001943:Breast Neoplasms / Q000000981:diagnostic imaging*; D005260:Female; D006801:Humans; D008168:Lung / Q000000981:diagnostic imaging; D008175:Lung Neoplasms / Q000000981:diagnostic imaging*; D008279:Magnetic Resonance Imaging / Q000379:methods*; D008297:Male; D064847:Multimodal Imaging / Q000379:methods*; D049268:Positron-Emission Tomography / Q000379:methods*
Breast cancer; Hybrid imaging; Lung cancer; Oncology; PET-MR imaging; Thoracic imaging